Roberts, Glore & Co’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.61M | Sell |
3,622
-121
| -3% | -$53.9K | 0.47% | 56 |
|
|
2025
Q1 | $1.81M | Sell |
3,743
-345
| -8% | -$167K | 0.55% | 48 |
|
|
2024
Q4 | $1.65M | Sell |
4,088
-67
| -2% | -$27K | 0.49% | 54 |
|
|
2024
Q3 | $1.93M | Sell |
4,155
-187
| -4% | -$87K | 0.56% | 44 |
|
|
2024
Q2 | $2.04M | Sell |
4,342
-243
| -5% | -$114K | 0.61% | 42 |
|
|
2024
Q1 | $1.92M | Sell |
4,585
-272
| -6% | -$114K | 0.57% | 48 |
|
|
2023
Q4 | $1.98M | Sell |
4,857
-281
| -5% | -$114K | 0.62% | 45 |
|
|
2023
Q3 | $1.79M | Sell |
5,138
-14
| -0.3% | -$4.87K | 0.59% | 44 |
|
|
2023
Q2 | $1.81M | Sell |
5,152
-33
| -0.6% | -$11.6K | 0.58% | 45 |
|
|
2023
Q1 | $1.63M | Sell |
5,185
-29
| -0.6% | -$9.14K | 0.55% | 50 |
|
|
2022
Q4 | $1.51M | Sell |
5,214
-332
| -6% | -$95.9K | 0.52% | 53 |
|
|
2022
Q3 | $1.61M | Sell |
5,546
-105
| -2% | -$30.4K | 0.57% | 50 |
|
|
2022
Q2 | $1.59M | Sell |
5,651
-390
| -6% | -$110K | 0.53% | 50 |
|
|
2022
Q1 | $1.58M | Hold |
6,041
| – | – | 0.45% | 55 |
|
|
2021
Q4 | $1.33M | Buy |
6,041
+386
| +7% | +$84.8K | 0.35% | 64 |
|
|
2021
Q3 | $1.03M | Buy |
+5,655
| New | +$1.03M | 0.31% | 78 |
|